5-nucleotidase and azathioprine-related bone-marrow toxicity

The Lancet

Volumn 342, Issue 8881, 1993, Pages 1245-1246

  Kerstens, PitJ S M ^a   Stolk, JanN ^a   Hilbrands, LuukB ^a   van de Putte, LevinusB A ^a   De Abreu, RonneyA ^a   Boerbooms, AgnesM T ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

5' NUCLEOTIDASE; ALLOPURINOL; AURANOFIN; AUROTHIOGLUCOSE; AZATHIOPRINE; COTRIMOXAZOLE; CYCLOSPORIN; PENICILLAMINE; PREDNISONE;

ADULT; BONE MARROW TOXICITY; CASE REPORT; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY TRANSPLANTATION; LETTER; LEUKOPENIA; MALE; PRIORITY JOURNAL;

5'-NUCLEOTIDASE; AZATHIOPRINE; BONE MARROW; CASE REPORT; HUMAN; LEUKOPENIA; MALE; MIDDLE AGE; SUPPORT, NON-U.S. GOV'T;

EID: 0027439224     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/0140-6736(93)92231-H     Document Type: Letter

References (6)

1. Pharmacogenetics of acute azathioprine toxicity: relationship to thiopurine methyltransferase genetic polymorphism
2. The importance of thiopurine methyltransferase activity for the use of azathioprine in transplant recipients
3. Azathioprine-induced myelosuppression in thiopurine methyltransferase deficient heart transplant recipient
4. Thiopurine-methyl-transferase activity to assess azathioprine myelotoxicity in renal transplant recipients
5. Enzymological analysis of purine metabolism in lymphoid cells
6. Human erythrocyte thiopurine methyltransferase: radiochemical assay and biochemical properties